Meet Inspiring Speakers and Experts at our 3000+ Global Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC Ltd : World’s leading Event Organizer

Conference Series LLC Ltd Conferences gaining more Readers and Visitors

Conference Series LLC Ltd Web Metrics at a Glance

  • 3000+ Global Events
  • 25 Million+ Visitors
  • 25000+ unique visitors per conference
  • 70000+ page views for every individual conference

Unique Opportunity! Online visibility to the Speakers and Experts

Previous Speakers

Vladimir Tolstikov

Vladimir Tolstikov

Director USA

Houkai Li

Houkai Li

Shanghai University of Traditional Chinese Medicine China

Ching-Wan Lam

Ching-Wan Lam

The University of Hong Kong Hong Kong

Alan Prem Kumar

Alan Prem Kumar

National University of Singapore Singapore

Jaleel Kareem Ahmed

Jaleel Kareem Ahmed

University of Babylon Iraq

Kenneth K Wu

Kenneth K Wu

CMU, NHRI and NTHU Taiwan

Takeshi Kimura

Takeshi Kimura

Ajinomoto Co., Inc Japan

Maximilian Zucker

Maximilian Zucker

Numares HEALTH AG Germany

Metabolomics Summit 2019

About Conference


Conference Series LLC LTD proudly announces the 14th International Conference on Metabolomics and Proteomics which will be held during March 28-29, 2019 , Osaka, Japan. The theme of conference is “Fifty Shades of Metabolomics and Methodological Development”. This is a Global Platform for the representatives from Universities and Institutes to communicate with the world class Scientists.

METABOLOMICS SUMMIT 2019 Conference will be an investigation of New research Innovation of Metabolomics and spread the most recent advancements and patterns in Metabolic profiling. Metabolomics and Cancer Research, LC-MS and GC-MS Techniques, lipidomics, Precision Medicine, Metabolomic Devices, Molecule metabolites, Proteomics, Protein Expression and more.

METABOLOMICS SUMMIT 2019 is attracting academicians including Professors, PhD Scholars, Students, Metabolomics & Proteomics researchers, Pharmaceutical Industrial Giants, Toxicology Societies and the people Associated with Nobel laureates in Health Care and Medicine, Life science experts, Pharmaceutical companies, Clinical Laboratories and Technicians, Bioinformatics Professionals, Research Institutes and members, Supply Chain companies, Manufacturing Companies, Training Institutes, Business Entrepreneurs.

Sessions & Tracks

The Organizing Committee of Conference Series LLC Ltd invites all the participants across the globe to attend the 14th International Conference on Metabolomics and Proteomics on March 28-29, 2019 , Osaka, Japan.

Track 1Metabolomic profiling

Metabolic profiling is the measurement of genetic modification and physiological, pathophysiological, and/or developmental stimuli in biological systems of the complement of low-molecular-weight metabolites and their intermediates that reflects the dynamic response. From a biological sample (typically urine, serum, or biological tissue extract)  The measurement and interpretation of the endogenous metabolite profile have provided many opportunities to investigate the changes induced by external stimuli (e.g., drug treatment) or enhance our knowledge of inherent biological variation within subpopulations."investigating preclinical drug development issues Metabolic profiling can complement conventional methodologies and other “omics” technologies." " in improving our understanding of phospholipidosis and peroxisome proliferation Case studies will illustrate the value of metabolic profiling.". " in support of toxicology and pathology investigations in preclinical drug development A key message will be that metabolic profiling offers huge potential to highlight biomarkers and mechanisms ."

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

10th International Conference on Proteomics, Genomics & Bioinformatics, May 16-17, 2018 Singapore

12th International Conference on STRUCTURAL AND MOLECULAR BI OLOGY, May 14-15, 2018 Osaka, Japan

2nd International Conference on Enzymology and Molecular Biology, March 20-21, 2017 Rome, Italy

2nd International Conference on Molecular Biology, Nucleic Acids & Molecular Medicine, August 31-September 01, 2017, Philadelphia, Pennsylvania, USA

9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-15, 2017 Paris, France

Relevant SocietiesMetabolomics Australia, Mass Spectrometry Society of Japan, Japanese Biochemistry Society, Molecular Biology Society of Japan, Taiwan Society for Biochemistry and Molecular Biology, Chinese Society of Biochemistry and Molecular Biology, New Zealand society of Biochemistry and Molecular Biology

Track 2: Metabolomics and Cancer Research

Cancer is an overwhelming sickness that changes the digestion system of a cell and the encompassing milieu.  in pharmaceutical examination Metabolomics is a generally quick and precise procedure that can be connected with either turning into an inexorably mainstream instrument in the life sciences or in a worldwide way to uncover new learning about organic frameworks. in subsidizing to growth research prompting NFCR has conveyed more than $330 million various leaps forward, including new anticancer medications and treatments, counteractive action methodologies, prior analytic systems. The Division of Cancer Biology (DCB) bolsters and encourages fundamental examination in every aspect of tumor science at scholastic establishments and exploration establishments over the United States and abroad. As a major aspect of the National Cancer Institute, the Federal Government's foremost office for growth research and preparing, DCB gives financing to research that examines the fundamental science behind all events of Cancer. Current metabolomic approaches is being utilized to find symptomatic Cancer biomarkers in the clinic, to find pathways included in disease that could be utilized for new targets and to screen metabolic biomarkers amid remedial mediation. for hearty approval of biomarkers for Cancer that could be helpful for its future forecast, conclusion and treatment Concentrating on growth through metabolomics could uncover metabolite stage. There have been numerous novel ways to deal with cancer therapeutics that have utilized a scope of various explanatory stages. At the point when Cancer digestion system meets frameworks science system models might manual for growth treatment.

Metabolomics has significant potential in pharmaceutical and clinical research, including the identification of new targets, the elucidation of the mechanism of action of new drugs, the characterization of safety and efficacy profiles, as well as the discovery of biomarkers for early disease diagnosis, prognosis, patient stratification, and treatment response monitorization. A systems biology approach how differences in biomolecular structure translate into a global rewiring of cancer metabolism at the genome, transcriptome, proteome, metabolome and fluxome level. opening unprecedented therapeutic opportunities, Cancer systems biology takes us beyond the Warburg effect.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

5th International Conference on Proteomics & Bioinformatics, September 01-03, 2015 Valencia, Spain

International Conference on Protein Engineering, October 26-28, 2015 Chicago, USA

13th International Conference on Metabolomics and Enzymology, May 23-24, 2018 New York, USA

9th International Conference on Bioinformatics, November 13-14, 2017 Paris, France

3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy

Relevant SocietiesMetabolomics Society, NIH West Coast Metabolomics Center, Metabolomics Workbench; Sciex Metabolomics Community, North West Metabolomics research centre, Canadian Society for Systems Biology, Human Metabolome Technologies (HMT), The International Society for Systems Biology (ISSB) , ISCB - International Society for Computational Biology, PhenoMeNal consortium, Canadian Society for Analytical Sciences and Spectroscopy, American Society for Biochemistry and Molecular Biology.

Track 3: Metabolomic Analysis

Metabolomics is a science concerned with the systematic study of the chemical products or metabolites that cells and organisms generate is related to young branch of “omics”. The downstream products of numerous genome-wide or proteome-wide interactions are metabolites, The metabolome (the sum of all metabolites in an organism) can be a very sensitive measure of an organism’s phenotype .In the study of environment-gene interactions, the identification of disease biomarkers and the discovery of drugs metabolomics particularly useful. metabolomics still struggles to cover even a tiny fraction of the metabolome, Unlike its older “omics” cousins, where complete or near-complete coverage of the genome or proteome is fairly routine. Typically succeed in identifying or characterizing fewer than 100 compounds Indeed, most human metabolomic studies published today, even those exploiting the latest and most sensitive LC-MS/MS technologies. The known human metabolome corresponds to less than 1%. we (and others) have started to undertake the systematic characterization of various human biofluid metabolomes, In an effort to help improve this situation. Biofluid metabolomes includes the human serum metabolome human cerebrospinal fluid metabolome the human saliva metabolome. We already turned our attention to characterizing the human urine metabolome.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

10th International Conference on Proteomics, Genomics & Bioinformatics, May 16-17, 2018 Singapore

12th International Conference on STRUCTURAL AND MOLECULAR BI OLOGY, May 14-15, 2018 Osaka, Japan

2nd International Conference on Enzymology and Molecular Biology, March 20-21, 2017 Rome, Italy

2nd International Conference on Molecular Biology, Nucleic Acids & Molecular Medicine, August 31-September 01, 2017, Philadelphia, Pennsylvania, USA

9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-15, 2017 Paris, France

Relevant SocietiesMetabolomics Australia, Mass Spectrometry Society of Japan, Japanese Biochemistry Society, Molecular Biology Society of Japan, Taiwan Society for Biochemistry and Molecular Biology, Chinese Society of Biochemistry and Molecular Biology, New Zealand society of Biochemistry and Molecular Biology.

Tack 4: Human Metabolomics

Metabolites can serve as a metabolic disease biomarker. In the study of biochemical reaction and signaling networks detection of such biomarkers plays a significant role. The multicomponent analysis of biological fluids, tissue and cell extracts using NMR spectroscopy and/or mass spectrometry (MS) Metabolic profiling, studies mainly involve metabolomic and metabonomic. In biological systems the measurement of the complement of low-molecular-weight metabolites and their intermediates that reflects the dynamic response to genetic modification and physiological, pathophysiological and/or developmental stimuli is known as Metabolic profiling (metabolomics/metabonomics).The current developments in metabolomics and metabolic profiling technologies have led to the discovery of several new metabolic biomarkers. complete and comprehensive curated collection of human metabolite and human metabolism data in the world is The Human Metabolome Database (HMDB).It contains records thousands of books, journal articles and electronic databases for more than 2180 endogenous metabolites. Metabolomic analyses like  mass spectra (MS) and Nuclear Magnetic resonance (NMR) performed on urine, blood and cerebrospinal fluid samples also contains by  HMDB In addition to its comprehensive literature-derived data. In the field of biochemists, clinical chemists, physicians, medical geneticists, nutritionists and members of the metabolomics community the HMDB is designed to address.

In January 2005 project launched funded by Genome Canada for The Human Metabolome Project is a $7.5 million . The purpose of the project is to facilitate metabolomics research through several objectives like to develop software tools for metabolomics, improve disease identification, prognosis and monitoring; provide a linkage between the human metabolome and the human genome provide insight into drug metabolism and toxicology.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

5th International Conference on Proteomics & Bioinformatics, September 01-03, 2015 Valencia, Spain

International Conference on Protein Engineering, October 26-28, 2015 Chicago, USA

13th International Conference on Metabolomics and Enzymology, May 23-24, 2018 New York, USA

9th International Conference on Bioinformatics, November 13-14, 2017 Paris, France

3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy

Relevant SocietiesMetabolomics Society, NIH West Coast Metabolomics Center, Metabolomics Workbench; Sciex Metabolomics Community, North West Metabolomics research centre, Canadian Society for Systems Biology, Human Metabolome Technologies (HMT), The International Society for Systems Biology (ISSB) , ISCB - International Society for Computational Biology, PhenoMeNal consortium, Canadian Society for Analytical Sciences and Spectroscopy, American Society for Biochemistry and Molecular Biology.

Tack 5: Single Cell Metabolomics

Metabolites found in a specific cell, organ, or organism as the full complement of small-molecule the term metabolome is used. In the area of cancer  single-cell metabolomics is the most interesting potential application. In other fields  like systems biology, stem cell research, aging, and the development of drug resistance; more generally, it could be used to discover cells’ chemical strategies for coping with chemical or environmental stress. Metabolomics provides a more immediate and dynamic picture of the functionality (i.e., of the phenotype) of a cell  relative to other single-cell “-omics” measurements,  but it is the most difficult to measure. Its very challenging to analysis of  metabolites by mass spectrometry  due to the very limited volume and inherent molecular complexity of the sample.   By aggregate analysis of multiple cells  Quantitative metabolomic analysis of individual cells provides information on the metabolic heterogeneity of cells . Quantitative analysis for a broad class of metabolites exhibiting both high sensitivity and selectivity can offer by MS Depending on the ionization method . Metabolites can be analyze  from broad range of biological samples, including single cells and small cell populations by Laser ablation electrospray ionization (LAESI).

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

10th International Conference on Proteomics, Genomics & Bioinformatics, May 16-17, 2018 Singapore

12th International Conference on STRUCTURAL AND MOLECULAR BI OLOGY, May 14-15, 2018 Osaka, Japan

2nd International Conference on Enzymology and Molecular Biology, March 20-21, 2017 Rome, Italy

2nd International Conference on Molecular Biology, Nucleic Acids & Molecular Medicine, August 31-September 01, 2017, Philadelphia, Pennsylvania, USA

9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-15, 2017 Paris, France

Relevant SocietiesMetabolomics Australia, Mass Spectrometry Society of Japan, Japanese Biochemistry Society, Molecular Biology Society of Japan, Taiwan Society for Biochemistry and Molecular Biology, Chinese Society of Biochemistry and Molecular Biology, New Zealand society of Biochemistry and Molecular Biology.

Track 6: Mass Spectrometry based Metabolomics

Critical component in metabolomics to analyze Mass spectrometry which seeks to answer biological questions through large-scale qualitative and quantitative analyses of the metabolome has been successfully exploited by  Laser ablation electrospray ionization (LAESI). An indispensable platform in biology and metabolomics offer an excellent combination of sensitivity and selectivity, and they have become MS based metabolomics techniques. The Main aim of  metabolomics  to characterize small molecule metabolites present in biological systems, promises immense potential for different areas such as medicine, environmental sciences, agronomy, etc. The rapidly growing area of "metabolomics," in which a large number of metabolites from body fluids, cells or tissue are detected quantitatively, in a single step, promises immense potential for a number of disciplines including early disease diagnosis, therapy monitoring, systems biology, drug discovery and nutritional science. Because of its ability to detect a large number of metabolites in intact biological samples reproducibly and quantitatively, nuclear magnetic resonance (NMR) spectroscopy has emerged as one of the most powerful analytical techniques in metabolomics.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

5th International Conference on Proteomics & Bioinformatics, September 01-03, 2015 Valencia, Spain

International Conference on Protein Engineering, October 26-28, 2015 Chicago, USA

13th International Conference on Metabolomics and Enzymology, May 23-24, 2018 New York, USA

9th International Conference on Bioinformatics, November 13-14, 2017 Paris, France

3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy

Relevant SocietiesMetabolomics Society, NIH West Coast Metabolomics Center, Metabolomics Workbench; Sciex Metabolomics Community, North West Metabolomics research centre, Canadian Society for Systems Biology, Human Metabolome Technologies (HMT), The International Society for Systems Biology (ISSB) , ISCB - International Society for Computational Biology, PhenoMeNal consortium, Canadian Society for Analytical Sciences and Spectroscopy, American Society for Biochemistry and Molecular Biology.

Track 7: Urine Metabolomics

In response to a specific disease or therapeutic intervention a prominent field emerged i.e Urine metabolomics for the discovery of non-invasive biomarkers that can detect subtle metabolic discrepancies . compared to other biofluids, Urine, is characterized by its ease of collection, richness in metabolites and its ability to reflect imbalances of all biochemical pathways within the body. Using urine sample for metabolomic analysis, samples must be immediately frozen to quench any biogenic and/or non-biogenic chemical reactions. Liquid chromatography (LC)-MS is unequivocally  Combined with the qualitative and quantitative capabilities of MS, due to the continuous improvements in its related technologies is the most analytical tool employed in urine metabolomics . The Urine Metabolome database contains detailed information about ~3100 small molecule metabolites found in human urine along with ~3900 concentration values. The  data fields contains by  metabolite are hyperlinked to other databases (KEGG, PubChem, ChEBI, Chemspider, DrugBank, PDB and Uniprot). The information derived from  chemical data, clinical data and molecular/biochemistry data.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

10th International Conference on Proteomics, Genomics & Bioinformatics, May 16-17, 2018 Singapore

12th International Conference on STRUCTURAL AND MOLECULAR BI OLOGY, May 14-15, 2018 Osaka, Japan

2nd International Conference on Enzymology and Molecular Biology, March 20-21, 2017 Rome, Italy

2nd International Conference on Molecular Biology, Nucleic Acids & Molecular Medicine, August 31-September 01, 2017, Philadelphia, Pennsylvania, USA

9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-15, 2017 Paris, France

Relevant SocietiesMetabolomics Australia, Mass Spectrometry Society of Japan, Japanese Biochemistry Society, Molecular Biology Society of Japan, Taiwan Society for Biochemistry and Molecular Biology, Chinese Society of Biochemistry and Molecular Biology, New Zealand society of Biochemistry and Molecular Biology.

Track 8: Clinical Metabolomics & Lipidomics

Metabolomics and lipidomics, intense apparatuses in frameworks science, expect to screen little metabolites present in organic examples. Contrasts in the species or measures of metabolites can be utilized to portray phenotypes and natural reactions to annoyances (ailments, hereditary adjustments, or nutritious and pharmacological medications). Mass spectrometer instrument, with high determination GC or UHPLC, gives unrivaled adaptability and affectability to choose particle response checking (SRM) tests for measuring endogenous metabolites and lipids utilizing Thermo Scientific TraceFinder and LC Quan programming. observing reduction status, deciding the viability of particular remedial conventions, and controlling the choice of particular helpful mediations approving and creating pre-clinical biomarkers for building up the vicinity of ailment is Translational Biomarker. Connecting the consequences of biomarker studies utilizing protein-protein association methodologies can help with frameworks science approaches and could prompt theory era and recognizable proof of new medication targets. Science Minister David Willetts has declared £48 million of new speculation to store research ventures went for handling wellbeing issues.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

5th International Conference on Proteomics & Bioinformatics, September 01-03, 2015 Valencia, Spain

International Conference on Protein Engineering, October 26-28, 2015 Chicago, USA

13th International Conference on Metabolomics and Enzymology, May 23-24, 2018 New York, USA

9th International Conference on Bioinformatics, November 13-14, 2017 Paris, France

3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy

Relevant SocietiesMetabolomics Society, NIH West Coast Metabolomics Center, Metabolomics Workbench; Sciex Metabolomics Community, North West Metabolomics research centre, Canadian Society for Systems Biology, Human Metabolome Technologies (HMT), The International Society for Systems Biology (ISSB) , ISCB - International Society for Computational Biology, PhenoMeNal consortium, Canadian Society for Analytical Sciences and Spectroscopy, American Society for Biochemistry and Molecular Biology.

Track 9 : Plant & Environmental Metabolomics

The Process include the examination of endogenous and exogenous low nuclear mass metabolites within a cell, tissue, or biofluid of a living thing in light of an external stressor is Metabolomics. The sub-control of natural metabolomics is the use of metabolomic methodologies to explore the associations of life shapes with their environment. Medication digestion framework is the method by which the body isolates and changes over pharmaceutical into dynamic invention substances. Toxicology is a branch of Medical Science that courses of action with the effects of manufactured compound used as a piece of the conclusion, treatment, or balancing activity of illness or other surprising condition on the body. Plant Metabolomics is to examine the plant structure at the sub-nuclear level giving non-uneven portrayal of the aggregate metabolite pool (metabolome) of plants under specific conditions. Utilizing Metabolomics, a superior comprehension of the connection amongst's qualities and the biochemical structure of a plant tissue in light of its condition (phenotype) can be gotten, and this data can be additionally used to survey quality capacity (genotype). Four joint U.S. additionally, Japanese research bunches have been rewarded financing totaling about $12 million (about Yen 960 million) to become new normally very much arranged methodologies to grow the production of inexhaustible biofuel and reduce pesticide utilize. Metabolomics is progressively being utilized to portray the communications of living beings with their common habitat. Ecological metabolomics is the use of metabolomics to portray the communications of creatures with their condition. Green frameworks science gives the way to explore this genotype– phenotype relationship without precedent for an essential way, joining genome-scale atomic estimations phenotyping and PC helped displaying approaches. Medication digestion is the procedure by which the body separates and changes over medicine into dynamic compound substances. Toxicology is a branch of Medical Science that arrangements with the impacts of synthetic compound utilized as a part of the analysis, treatment, or anticipation of ailment or other anomalous condition on the body.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

10th International Conference on Proteomics, Genomics & Bioinformatics, May 16-17, 2018 Singapore

12th International Conference on STRUCTURAL AND MOLECULAR BI OLOGY, May 14-15, 2018 Osaka, Japan

2nd International Conference on Enzymology and Molecular Biology, March 20-21, 2017 Rome, Italy

2nd International Conference on Molecular Biology, Nucleic Acids & Molecular Medicine, August 31-September 01, 2017, Philadelphia, Pennsylvania, USA

9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-15, 2017 Paris, France

Relevant SocietiesMetabolomics Australia, Mass Spectrometry Society of Japan, Japanese Biochemistry Society, Molecular Biology Society of Japan, Taiwan Society for Biochemistry and Molecular Biology, Chinese Society of Biochemistry and Molecular Biology, New Zealand society of Biochemistry and Molecular Biology.

Track 10 : Metabolic Syndrome

Metabolomics is associated with inquire about a couple of human sicknesses, to upgrade their assurance and repugnance, and to plot better accommodating frameworks. Metabolomic profiling has been used to recognize novel biomarkers and systems of cardiovascular illness hazard. Sustenance and Metabolism Center and Center for Human Genetics at Duke University where the examination is proceeding with National Institutes of Health grants . Metabolomics can give certain inclinations in regard to other "omics" progressions (genomics, transcriptomics, proteomics) in diabetes look into. CEDAM (Center for Endocrinology, Diabetes and Metabolism) investigation is centered around a seat to-bedside approach, taking examination through from key science divulgence to clinical application. This is energized by recurring pattern MRC Experimental Medicine and Biomarker Grants and enhanced by the close-by region of lab workplaces, Welcome Trust Clinical Research Facility and the Queen Elizabeth Hospital (University Hospital NHS Foundation Trust). Metabolomic approach gives novel encounters into the robotic investigations of antitumor solutions from a point specific from conventional drug examinations. Distinctive new headways have been used for method change of metabolomics. Particular advances have nudged the utilization of metabolomics in a combination of different examination zones spreading over fundamental, biomedical, and clinical sciences.

Metabolomic profiling has been utilized to recognize novel biomarkers and components of cardiovascular infection chance. Metabolomics requirements for bioinformatics traverse through information and data administration, crude scientific information preparing, metabolomics measures and metaphysics, factual examination and information mining, information incorporation and numerical demonstrating of metabolic systems inside a structure of frameworks science. The real methodologies in metabolomics, alongside the cutting edge scientific instruments utilized for information age, are checked on with regards to these particular bioinformatics needs. Endocrinology is a restorative claim to fame that arrangements with the analysis and treatment of maladies identified with hormones, especially the biochemical procedures engaged with the body's ordinary working. Metabolomics gives a chance to build up the precise investigation of the metabolites and has been connected to finding biomarkers and annoyed pathways which can clear up the activity component of conventional Chinese prescriptions (TCM).

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

5th International Conference on Proteomics & Bioinformatics, September 01-03, 2015 Valencia, Spain

International Conference on Protein Engineering, October 26-28, 2015 Chicago, USA

13th International Conference on Metabolomics and Enzymology, May 23-24, 2018 New York, USA

9th International Conference on Bioinformatics, November 13-14, 2017 Paris, France

3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy

Relevant SocietiesMetabolomics Society, NIH West Coast Metabolomics Center, Metabolomics Workbench; Sciex Metabolomics Community, North West Metabolomics research centre, Canadian Society for Systems Biology, Human Metabolome Technologies (HMT), The International Society for Systems Biology (ISSB) , ISCB - International Society for Computational Biology, PhenoMeNal consortium, Canadian Society for Analytical Sciences and Spectroscopy, American Society for Biochemistry and Molecular Biology.

Track 11: Metabolomics in Precision Medicine

Metabolomics, the post-genomic examination of the particles and strategies that make up absorption framework, appears as a potentially radical better approach for taking a gander at science and disease. Accuracy Medicine is an approach to manage finding and making pharmaceuticals and antibodies that passes on unrivaled outcomes for patients, by fusing clinical and sub-nuclear information to fathom the natural introduce of contamination. Pharmacometabolomics educates and compliments pharmacogenomics and together they give building pieces to Quantitative and Systems Pharmacology. Accuracy offers cutting edge answers for amplify your accomplishment in translational research. The appearance of gigantic parallel sequencing is mindful of a change in outlook in biomarker disclosure and clinical preliminary plan while in transit to what is currently called "biomarker-driven tumor solution" or "accuracy medication." Complementing generous dares to exhaustively reinforce investigation, change, and headway, the President's 2016 Budget will give a $215 million theory to the National Institutes of Health (NIH), together with the Food and Drug Administration (FDA), and the Office of the National Coordinator for Health Information Technology (ONC) to support this effort.

Pharmacometabolomics-in which vast biochemical information catching impacts of genome, gut microbiome and condition exposures is uncovering data about metabotypes and treatment results, and making metabolic marks as new potential biomarkers. The Precision Medicine Initiative assigns $70 million to the National Cancer Institute to build examine into genomic drivers of tumor, recognize those objectives, and grow new medications. Exactness Medicine alludes to the fitting of restorative treatment to the individual qualities of every patient. It doesn't actually mean the making of medications or therapeutic gadgets that are one of a kind to a patient, yet rather the capacity to group people into subpopulations that vary in their vulnerability to a specific illness, in the science or potentially visualization of those ailments they may create, or in their reaction to a particular treatment.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

10th International Conference on Proteomics, Genomics & Bioinformatics, May 16-17, 2018 Singapore

12th International Conference on STRUCTURAL AND MOLECULAR BI OLOGY, May 14-15, 2018 Osaka, Japan

2nd International Conference on Enzymology and Molecular Biology, March 20-21, 2017 Rome, Italy

2nd International Conference on Molecular Biology, Nucleic Acids & Molecular Medicine, August 31-September 01, 2017, Philadelphia, Pennsylvania, USA

9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-15, 2017 Paris, France

Relevant SocietiesMetabolomics Australia, Mass Spectrometry Society of Japan, Japanese Biochemistry Society, Molecular Biology Society of Japan, Taiwan Society for Biochemistry and Molecular Biology, Chinese Society of Biochemistry and Molecular Biology, New Zealand society of Biochemistry and Molecular Biology.

Track 12: Frontiers of Metabolomics Research

Metabolomic studies can provoke enhanced perception of disease instruments and to new demonstrative markers and furthermore redesigned understanding of medication for solution or xenobiotic impact and expanded capacity to foresee singular variety in sedate reaction phenotypes. Howard University Center for Computational Biology and Bioinformatics (CCBB) is to invigorate and propel the usage of computational approaches to manage the examination of biomedical and disease shapes. New programming and progressively advanced NMR metabolite ghastly databases are driving the fascinating limits of NMR spectroscopy to perceive and assess little particles in respond in due order regarding examinations of metabolite biomarkers and metabolic motion. NIH Awards $1.6M to Fund microRNA Biomarker Research in Cancer, Alzheimer's Disease . The Bill and Melinda Gates Foundation today revealed $7.7 million in sponsoring for 10 new permits to recognize biomarkers for diagnosing tuberculosis (TB) in low-resource settings. NMR metabolomics to exhibit that disparate natural signs are transduced into regular metabolomic changes that are "detected" by metabolite responsive controllers.

Metabolomics—a frameworks science way to deal with describing metabolites created in biochemical pathways—is adding to numerous investigations of infection movement and treatment, despite the fact that it has not yet been widely connected in look into on metabolic annoyances related with liquor manhandle. Digestion fundamentally influences sedate security and viability, deciding the metabolic profile of a medication is a basic piece of medication improvement. The use of a LC– MS-based metabolomic approach has increased more boundless use in distinguishing drug metabolites, creating metabolic maps and loaning signs to instruments of bioactivation. Late advances in metabolomics and computational investigation have developed our thankfulness for the part of particular metabolic pathways in directing cell destiny.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

5th International Conference on Proteomics & Bioinformatics, September 01-03, 2015 Valencia, Spain

International Conference on Protein Engineering, October 26-28, 2015 Chicago, USA

13th International Conference on Metabolomics and Enzymology, May 23-24, 2018 New York, USA

9th International Conference on Bioinformatics, November 13-14, 2017 Paris, France

3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy

Relevant SocietiesMetabolomics Australia, Mass Spectrometry Society of Japan, Japanese Biochemistry Society, Molecular Biology Society of Japan, Taiwan Society for Biochemistry and Molecular Biology, Chinese Society of Biochemistry and Molecular Biology, New Zealand society of Biochemistry and Molecular Biology.

Track 13: Metabolomic Devices

Metabolomics, then again metabonomics, a rising field of biochemical investigation, is an equal technique to genomics, transcriptomics, and proteomics. Coordinate quantitative estimations of metabolite articulations in pee, serum, plasma, and tissue are significant for the examination of natural methods in common and disease states. Ensuing to the amount of metabolites in a characteristic illustration is broad segment science accept a basic part in metabolomic explore. Nuclear alluring resonation (NMR) spectroscopy is particularly skilled for centered examination since it is quantitative, reproducible, and reasonable for complex cases, for instance, blood, pee, or tissue expels with for all intents and purposes zero getting ready. Thermo Fisher, AB SCIEX, and Bruker in like manner offer instruments for imaging MS, also called MALDI imaging. To meet troubles of accessibility and data compromise, the metabolomics amass has a couple of exercises to develop data vaults. Cases are Metabolights in the United Kingdom, reinforced by the European COSMOS (COordination of Standards in Metabolomics) consortium that is making metabolomics data standards, and Metabolomics Workbench, which intends to be the database for NIH-sponsored metabolomics wanders. Thermo Fisher collaborates with Fiehn on mzcloud.org, a free network database that incorporates real and virtual MS spectra with obscure mixes to be commented on as they are recognized.

Metabolomics is a generally new high-throughput innovation that goes for estimating every single endogenous metabolite inside a natural example in an unprejudiced manner. The subsequent metabolic profiles might be viewed as utilitarian marks of the physiological state, and have been appeared to contain impacts of hereditary direction and additionally ecological variables. Ultra execution fluid chromatography (UPLC) utilizes particles littler than 2 μm in distance across to accomplish unrivaled determination, speed, and affectability contrasted and superior fluid chromatography (HPLC). Agilent Mass Profiler Professional (MPP) is intended to process metabolomics information and results obtained from different systematic procedures to help biomarker revelation, finding an organic mark (unique mark) or mapping pathways. Particle versatility spectrometry (IMS), a gas-stage electrophoretic method, makes conceivable the division of particles in the gas stage as indicated by their charge, shape, and size. IMS can be joined with mass spectrometry (MS), adding three noteworthy advantages to conventional lipidomic approaches.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

10th International Conference on Proteomics, Genomics & Bioinformatics, May 16-17, 2018 Singapore

12th International Conference on STRUCTURAL AND MOLECULAR BI OLOGY, May 14-15, 2018 Osaka, Japan

2nd International Conference on Enzymology and Molecular Biology, March 20-21, 2017 Rome, Italy

2nd International Conference on Molecular Biology, Nucleic Acids & Molecular Medicine, August 31-September 01, 2017, Philadelphia, Pennsylvania, USA

9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-15, 2017 Paris, France

Relevant SocietiesMetabolomics Society, NIH West Coast Metabolomics Center, Metabolomics Workbench; Sciex Metabolomics Community, North West Metabolomics research centre, Canadian Society for Systems Biology, Human Metabolome Technologies (HMT), The International Society for Systems Biology (ISSB) , ISCB - International Society for Computational Biology, PhenoMeNal consortium, Canadian Society for Analytical Sciences and Spectroscopy, American Society for Biochemistry and Molecular Biology.

Track 14: Analytical Platforms in Metabolomics

In metabolomics, genuine undertakings are placed assets into the headway of reasonable logical strategies. Metabolomics, the most youthful field in the 'omics family, is developing quickly. Growing straightforwardly behind genomics, transcriptomics, and proteomics, metabolomics is the broad examination of little molecule metabolites. Ensuing to most metabolites are delivered by enzymatic proteins that result from quality articulation, and metabolites give animals their biochemical properties, the metabolome joins genotype with phenotype. Metabolomics is up 'til now developing, notwithstanding, as traders alter division and revelation instruments to meet its challenges and the examination bunch decodes and consolidates the amazing data they are picking up. The late speedy headway of an extent of investigative stages, including GC, HPLC, UPLC, CE coupled to MS and NMR spectroscopy, could enable segment, recognizable proof, depiction and assessment of such metabolites and related metabolic pathways. Continued with change of these demonstrative stages will enliven sweeping use and coordination of metabolomics into structures science. NIH Awards $1.6M to Fund microRNA Biomarker Research in Cancer, Alzheimer's Disease . The Bill and Melinda Gates Foundation today pronounced $7.7 million in financing for 10 new concedes to recognize biomarkers for diagnosing tuberculosis (TB) in low-asset settings.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

5th International Conference on Proteomics & Bioinformatics, September 01-03, 2015 Valencia, Spain

International Conference on Protein Engineering, October 26-28, 2015 Chicago, USA

13th International Conference on Metabolomics and Enzymology, May 23-24, 2018 New York, USA

9th International Conference on Bioinformatics, November 13-14, 2017 Paris, France

3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy

Relevant SocietiesMetabolomics Australia, Mass Spectrometry Society of Japan, Japanese Biochemistry Society, Molecular Biology Society of Japan, Taiwan Society for Biochemistry and Molecular Biology, Chinese Society of Biochemistry and Molecular Biology, New Zealand society of Biochemistry and Molecular Biology.

Track 15: Metabolic Modelling

Digestion is a basic cell system, and its glitch can be an imperative giver to various human ailments. Metabolites can fill in as a metabolic affliction biomarker. An acknowledgment of such biomarkers expects a tremendous part in the examination of biochemical reaction and hailing frameworks. Metabolic profiling, metabolomic and metabonomic focuses generally incorporate the multicomponent examination of regular fluids, tissue and cell evacuates using NMR spectroscopy as well as mass spectrometry (MS). Metabolic profiling (metabolomics/metabonomics) is the estimation in natural systems of the supplement of low-sub-nuclear weight metabolites and their intermediates that mirrors the dynamic response to innate change and physiological, pathophysiological, and additionally developmental lifts. The present advancements in metabolomics and metabolic profiling innovations have prompted the revelation of a few new metabolic biomarkers. Through the NIH Common Fund's Increasing Metabolomics Research Capacity Program External Web Site Policy, the NIH has given more than $65 million to animate the field of metabolomics all through the accompanying five years. The target of this financing framework is to move a couple of focus ranges, including extensive metabolomics resource focuses, metabolomics advancement change, metabolomics reference standards amalgamation, and getting ready and informative activities in metabolomics.

Metabolic profiling is the estimation in natural frameworks of the supplement of low-atomic weight metabolites and their intermediates that mirrors the dynamic reaction to hereditary change and physiological, pathophysiological, as well as formative boosts. The accessibility of human genome successions and transcriptomic, proteomic and metabolomic information furnishes us with a testing chance to create computational methodologies for precise examination of metabolic issue. The Translational Biomarker Discovery Core's Function is to give Biomarker disclosure administrations to essential researchers and clinicians doing research being connected to enhancing clinical results for patients. Late mechanical advances in both DNA sequencing and metabolite profiling permit the utilization of wide range, untargeted metabolite profiling to produce phenotypic information for all-inclusive affiliation ponders that explore quantitative hereditary control of digestion inside species.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

5th International Conference on Proteomics & Bioinformatics, September 01-03, 2015 Valencia, Spain

International Conference on Protein Engineering, October 26-28, 2015 Chicago, USA

13th International Conference on Metabolomics and Enzymology, May 23-24, 2018 New York, USA

9th International Conference on Bioinformatics, November 13-14, 2017 Paris, France

3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy

Relevant SocietiesMetabolomics Society, NIH West Coast Metabolomics Center, Metabolomics Workbench; Sciex Metabolomics Community, North West Metabolomics research centre, Canadian Society for Systems Biology, Human Metabolome Technologies (HMT), The International Society for Systems Biology (ISSB) , ISCB - International Society for Computational Biology, PhenoMeNal consortium, Canadian Society for Analytical Sciences and Spectroscopy, American Society for Biochemistry and Molecular Biology.

Track 16: Case Reports

Case reports are an indispensable direct wellspring of affirmation in pharmaceutical and a gadget consistently used as a piece of training to exchange information and make a more expanded journey for evidence. A not too bad case report will be clear about the centrality of the recognition being represented. A decent case report will be clear about the significance of the perception being accounted for. Notwithstanding the "proof of what happened", single or various cases are an imperative reason for further and further developed research on determination, treatment ampleness, reasons and aftereffects of illness. Case reports may be first to give signs in recognizing another affliction or hostile prosperity affect from an introduction. Case reports must be real, justifiable, instructive and clinically intriguing to a worldwide group of onlookers of specialists, learners and analysts in all careful subspecialties, and clinicians in related fields.

Case report depicts the ongoing history of a moderately aged marathon sprinter experiencing asymptomatic ischemic coronary illness at high hazard for SCD and delineates the clinical pathway. The premise of this proof is the point by point data from the case reports of unique individuals which advises both our clinical research and our day by day clinical care. In drug, a case report is a point by point report of the side effects, signs, conclusion, treatment, and follow-up of an individual patient. Case reports may contain a statistic profile of the patient, yet generally depict an unordinary or novel event. Some case reports likewise contain a writing survey of other announced cases.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

10th International Conference on Proteomics, Genomics & Bioinformatics, May 16-17, 2018 Singapore

12th International Conference on STRUCTURAL AND MOLECULAR BI OLOGY, May 14-15, 2018 Osaka, Japan

2nd International Conference on Enzymology and Molecular Biology, March 20-21, 2017 Rome, Italy

2nd International Conference on Molecular Biology, Nucleic Acids & Molecular Medicine, August 31-September 01, 2017, Philadelphia, Pennsylvania, USA

9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-15, 2017 Paris, France

Relevant Societies: Metabolomics Australia, Mass Spectrometry Society of Japan, Japanese Biochemistry Society, Molecular Biology Society of Japan, Taiwan Society for Biochemistry and Molecular Biology, Chinese Society of Biochemistry and Molecular Biology, New Zealand society of Biochemistry and Molecular Biology.

Track 17: Proteomics from Discovery to Function

Proteomics is an emerging field that has been highly enabled by the human genome project. Proteins are the products of genes, the machinery of the cells in our bodies. When genes are disrupted, the proteins are also affected. When pathogens infect us, causing disease, proteins play a key role in signaling the presence and ridding us of these invaders. Almost every process that occurs in our cells – from the metabolization of simple sugar to the division of cells – is dependent on proteins for smooth operation. In general, proteomics seeks to detect and quantify as many proteins as possible.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

5th International Conference on Proteomics & Bioinformatics, September 01-03, 2015 Valencia, Spain

International Conference on Protein Engineering, October 26-28, 2015 Chicago, USA

13th International Conference on Metabolomics and Enzymology, May 23-24, 2018 New York, USA

9th International Conference on Bioinformatics, November 13-14, 2017 Paris, France

3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy

Relevant SocietiesMetabolomics Society, NIH West Coast Metabolomics Center, Metabolomics Workbench; Sciex Metabolomics Community, North West Metabolomics research centre, Canadian Society for Systems Biology, Human Metabolome Technologies (HMT), The International Society for Systems Biology (ISSB) , ISCB - International Society for Computational Biology, PhenoMeNal consortium, Canadian Society for Analytical Sciences and Spectroscopy, American Society for Biochemistry and Molecular Biology.

Track 18: Proteomics for Bioinformatics

Bioinformatics is both an umbrella term for the body of biological studies that use computer programming as part of their methodology, as well as a reference to specific analysis "pipelines" that are repeatedly used, particularly in the fields of genetics and genomics. Common uses of bioinformatics include the identification of candidate genes and nucleotides.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

10th International Conference on Proteomics, Genomics & Bioinformatics, May 16-17, 2018 Singapore

12th International Conference on STRUCTURAL AND MOLECULAR BI OLOGY, May 14-15, 2018 Osaka, Japan

2nd International Conference on Enzymology and Molecular Biology, March 20-21, 2017 Rome, Italy

2nd International Conference on Molecular Biology, Nucleic Acids & Molecular Medicine, August 31-September 01, 2017, Philadelphia, Pennsylvania, USA

9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-15, 2017 Paris, France

Relevant SocietiesMetabolomics Australia, Mass Spectrometry Society of Japan, Japanese Biochemistry Society, Molecular Biology Society of Japan, Taiwan Society for Biochemistry and Molecular Biology, Chinese Society of Biochemistry and Molecular Biology, New Zealand society of Biochemistry and Molecular Biology.

Track 19: Protein Expression and Analysis

Protein articulation alludes to the manner by which proteins are orchestrated, changed and controlled in living creatures. In protein investigate, the term can apply to either the question of study or the research facility strategies required to fabricate proteins. Protein examination is the bioinformatics investigation of protein structure, protein association and capacity utilizing database seeks, succession correlations, auxiliary and practical expectations.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

5th International Conference on Proteomics & Bioinformatics, September 01-03, 2015 Valencia, Spain

International Conference on Protein Engineering, October 26-28, 2015 Chicago, USA

13th International Conference on Metabolomics and Enzymology, May 23-24, 2018 New York, USA

9th International Conference on Bioinformatics, November 13-14, 2017 Paris, France

3rd International Conference on Lipid Science & Technology, December 11-12, 2017 Rome, Italy

Metabolomics Australia, Mass Spectrometry Society of Japan, Japanese Biochemistry Society, Molecular Biology Society of Japan, Taiwan Society for Biochemistry and Molecular Biology, Chinese Society of Biochemistry and Molecular Biology, New Zealand society of Biochemistry and Molecular Biology.

Track 20: Proteomics and its Medicinal Research

Customized drug plans to tailor medications to accomplish the best result for singular patients, instead of treating patients with a 'one size fits all' approach. Customized prescription, additionally named exactness pharmaceutical, is a medicinal methodology that isolates patients into various gatherings—with restorative choices, practices, mediations as well as items being custom-made to the individual patient in view of their anticipated reaction or danger of malady.

Relevant Conferences: Metabolomics Summit 2019 | Metabolomics conferences

10th International Conference on Proteomics, Genomics & Bioinformatics, May 16-17, 2018 Singapore

12th International Conference on STRUCTURAL AND MOLECULAR BI OLOGY, May 14-15, 2018 Osaka, Japan

2nd International Conference on Enzymology and Molecular Biology, March 20-21, 2017 Rome, Italy

2nd International Conference on Molecular Biology, Nucleic Acids & Molecular Medicine, August 31-September 01, 2017, Philadelphia, Pennsylvania, USA

9th International Conference and Expo on Proteomics and Molecular Medicine, November 13-15, 2017 Paris, France

Relevant SocietiesMetabolomics Society, NIH West Coast Metabolomics Center, Metabolomics Workbench; Sciex Metabolomics Community, North West Metabolomics research centre, Canadian Society for Systems Biology, Human Metabolome Technologies (HMT), The International Society for Systems Biology (ISSB) , ISCB - International Society for Computational Biology, PhenoMeNal consortium, Canadian Society for Analytical Sciences and Spectroscopy, American Society for Biochemistry and Molecular Biology.

Market Analysis

Summary:

Metabolomics is an emerging field which combines strategies to identify and quantify cellular metabolites using sophisticated analytical technologies with the application of statistical and multi-variant methods for information extraction and data interpretation. Metabolomics is the study of small metabolites. Metabolomics Conference deals with topics like Bioinformatics, proteomics, systems biology, Analytical Techniques like NMR, GC-MS, LC-MS and CE-MS, Lipidomics, Metabolic Modelling, Metabolic profiling, clinical metabolomics, Translational sciences, Mass spectrometry, Metabolomics Syndrome, HPLC and CE based metabolomics and more.  Metabolomics - the new "omics" - is a dynamic and developing field, joining genomics, transcriptomics and proteomics in empowering an integrative frameworks science methodology to drug discovery and development. In spite of the fact that metabolomics is still at an early evolutionary stage it is conjecture that throughout the following decade the biopharma business will apply this innovation all the more generally in drug development and information.

'The Future of Metabolomics' gives fully fledged understanding into the compelling utilization of metabolomics all through drug discovery, preclinical development and clinical trials. The report also highlights the use of metabolomics in maximizing and sustaining revenues post-marketing and in the development of clinical diagnostics.

Importance & Scope:

Metabolomics is now being extensively used in pharmaceutical and biotechnology industries for biomarker and drug discovery; pharmaceutical and biotechnology industries are expected to grow at a high rate in coming years, which is expected to boost the growth of the market.

The National Institutes of Health said that they are to invest $14.3 million for metabolomics research, potentially investing more than $51.4 million over five years, to accelerate an emerging field of biomedical research known as metabolomics. As per National Centre for Biotechnology Information. Metabolomics has matured over the past 10 years. Over 300 studies have been completed over the past 5 years.

Why Osaka, Japan?

Japan is the second largest Life science market in the world after USA, Occupying about 10% of Market in each of the global drug and Medical devices market. According to Data monitor, the Japanese biotechnology market had a total revenue of $ 43.3 Billion in 2013 . By 2017, the market is expected to grow to $ 53.8 Billion.

The Japanese pharmaceutical market is the world’s second-largest, with 2013 sales estimated at $115 billion. Japan accounts for a little less than 10 percent of the global Pharma market, compared with 38.4 percent for the U.S. and 20.7 percent for Western Europe

The Japanese market is a promising region for metabolomics companies, as a high amount of metabolomics research is being conducted in the country.

Why to attend ???

Meet Your Target Market With recent business reports on Metabolomics making news which manifests the tremendous growth in market value for metabolomics technology till 2019. Since metabolomics interrelated with omics sciences like Genomics, precision Medicine, Proteomics, Lipidomics, Fluxomics and Transcriptomics, it would be a great opportunity for companies dealing with Analytical instruments useful in these fields. Also many upcoming students and researchers can benefit themselves by participating world class International workshops, symposia during the conference which will be conducted by experts in the respective fields.

Major Metabolomics Related Associations around the Globe :

Metabolomics Society

American association for the advancement of science

American association for clinical chemistry 

American association for cancer research

American association of pharmaceutical scientists

Association for Consumer Research (ACR)

American cancer society

Bioinformatics society of India

Nutrigenomics Organization

The British Society for Genetic Medicine

The Genetics Society

Netherlands metabolomics center

The Australian biotechnology association

Human Proteome Organization

Indiana Proteomics Consortium

Proteome Society

European federation of biotechnology

Australasian Proteomics Society

Clinical Genetics Society

Major Metabolomics Related Research Units in Japan :

RIKEN Center for Sustainable Resource Science

Institute for Advanced Biosciences, Keio University

Human Metabolome Technologies

Osaka University

University of Tokyo

Kyoto University

University of Tsukuba

Nagoya University

Hokkaido University

University of Tsukuba

Target Audience:

Directors/Managers & Business Delegates, Director of Laboratories, Universities, Industries, Investigators, Post-Doctoral Fellows, Research and Diagnostic Laboratories, Clinical Fellows, Students, Biomedical Research companies. 

Rise in the number of clinical trials, toxicological studies, and health awareness for nutritional products, rapid growth of metabolomics data analysis software and solutions, and use of metabolomics as diagnostics tool for biomarker screening of diseases is expected to propel the growth of this market.

Glance at Market of Metabolomics:

The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibits the growth of the metabolomics market to a certain extent. Metabolomics science is used extensively in biomarker discovery and drug assessment. Thus, the rapid growth experienced by pharmaceutical and biotechnology industries is assisting the growth of the metabolomics market.

In 2013, North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The global metabolomics market was valued at $565 million in 2014 and is expected to grow at a CAGR of 30% from 2014 to 2019.

Statistics which shows growth in importance of Metabolomics &Proteomics:

Metabolomics Market Worth $2,100 Million by 2019 - New Report by  Markets and Markets.

The global proteomics market is expected to reach US$ 31 billion by 2022, registering a CAGR of 11.0% during the forecast period. Increasing demand for customized medicine, rising genetic and birth disorders, expanded subsidizing for proteomics ventures, and technical advancements are mainly driving the market.

Statistics of Industries Associated with Metabolomics :

North America was the market leader with a share of ~42% of the global market, followed by Europe with a share of ~38%. The presence of a large number of analytical equipment manufacturers has contributed significantly to the North American and European metabolomics market. However, the Asia-Pacific region represents a significant growth opportunity for the metabolomics market during the forecast period of 2014 to 2019. The APAC market is expected to grow at a CAGR of 23% during the forecast period. The growth in this market is driven by the growing pharmaceutical and biotechnology industries.

The major players in the metabolomics market include Thermo Fisher Scientific (U.S.), Metabolon, Inc. (U.S.), Danaher Corporation (U.S.), Shimadzu Corporation (Japan), Waters Corporation (U.S.), Agilent Technologies (U.S.), and Bruker Corporation (U.S.).

Fund Allotment towards Metabolomics Research :

The National Institutes of Health has provided tens of millions of dollars in new funding to support three new Comprehensive Metabolomics Centers at Mayo Clinic, the University of Kentucky, and the University of Florida.

These three centers will receive an estimated $9 million to $10 million each over the next five years to create resources and initiate research programs that will ramp up the national metabolomics science capabilities.

NIH provided $14.3 million to fund the launch of three other metabolomics resource centers at the University of Michigan, the Research Triangle Institute, and the University of California, Davis.

Michigan Regional Comprehensive Metabolomics Resource Core (MRC2)

NIH    West Coast Metabolomics Center at UC Davis

Southeast Center for Integrated Metabolomics (SECIM)

Metabolomics Core at Mayo Clinic

Research Center for Stable Isotope Resolved Metabolomics

Funding to UC San Diego for this project is $6 million over five years, part of a total investment by the NIH of $51.4 for the metabolomics project. The awards are supported by the NIH Common Fund.

Metabolomic Diagnostics is engaged in a study called Improved, which has received  €6m in European FP7 funding.

Mayo Clinic is one of six new federally-funded Comprehensive Metabolomics centres to support medical research on metabolomics — the study, at the cellular level, of how molecules are metabolized in the body. The award from the National Institutes of Health (NIH) is for $8.8 million over five years. 

Past Conference Report

Metabolomics Congress 2018

The 11th International Conference and Exhibition on Metabolomics & Systems Biology, Metabolomics Congress 2018 was held in Tokyo, Japan during May 17-19, 2018.

Metabolomics Congress 2018 has welcomed the new era of Metabolomics; a futuristic arena for treatment of diseases, clasping a promising tomorrow. The highly exalted conference hosted by Conference Series LLC ltd was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to Metabolomics and Cancer, covering all the possible research areas.  

The conference aimed a parallel rail with theme “Metabolomics: From Fundamentals to Clinical Applications”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Metabolomics and Cancer Research, Analytical Techniques in Metabolomics, Applications of Separation Sciences in Metabolomics, Frontiers of Metabolomics Research, Systems biology and Computational Biology, Bioinformatics and Advancements, Clinical Metabolomics and Lipidomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Metabolomics with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.

The Organizing Committee would like to thank the chair members Dr.Kevin Contrepois from Michael Snyder laboratory,USA and Dr.Joseph Fomusi Ndisang, University of Saskatchewan College of Medicine,Canada for their contributions which resulted in smooth functioning of the conference.

A series of invited lectures by Honorable guests and members of the Keynote Forum marked the commencement of the event. Prominent scientists like Jaleel Kareem Ahmed, University of Babylon, Iraq; Takeshi Kimura, Ajinomoto Co.,Inc, Japan; A.Vieira, Simon Fraser University, Canada; Kevin Contrepois from Michael Snyder laboratory,USA; Joseph Fomusi Ndisang, University of Saskatchewan College of Medicine,Canada; Nadia Mudher Sulaiman from University of Babylon, Iraq; Sergey Gorianov, from RUDN,Russian Federation; Anuri Shah from King’s College London, UK; Ya-Ju Hsieh from Molecular medicine Research center, Taiwan; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series LLC ltd is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artefact.

Conference Series LLC ltd  offers its heartfelt appreciation to all the media partners for the promotion of our event to glory.
Conference Series LLC ltd  on behalf of the conference, congratulates the Best poster awardees for their outstanding performance in the field of Metabolomics and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

Conference Series LLC ltd  11th International Conference and Exhibition on Metabolomics would not have reached the pinnacle if not with the support of international, multi-professional steering committee and coordination of the Journal of Metabolomics: Open Access, Journal of Computer Science and Systems Biology; hence, we express our deep sense of gratitude.

After the successful completion of 13 consecutive conferences we are glad to announce our next upcoming conferences which is going to be held in Japan is

“14th International Conference and Exhibition on Metabolomics and Proteomics” which is going to be held during March 28-29, 2019 in osaka,Japan.

Mark your calendars; we are hoping to see you soon!

Let us meet again @ Metabolomics Summit 2019


Past Reports  Gallery  

Metabolomics Congress 2017
 

The 8th International Conference and Exhibition on Metabolomics & Systems Biology, Metabolomics Congress 2017 was held in Singapore, during May 08 - 10, 2017.

Metabolomics Congress 2017 has welcomed the new era of Metabolomics; a futuristic arena for treatment of diseases, clasping a promising tomorrow. The highly exalted conference hosted by Conference Series llc LTD was marked with the attendance of young and brilliant researchers, business delegates and talented student communities representing more than 20 countries around the world. The conference has tried grounding every aspect related to Metabolomics and Cancer, covering all the possible research areas and crux.  

The conference aimed a parallel rail with theme “Rise of New Era in Metabolomics Research”. The meeting engrossed a vicinity of cognizant discussions on novel subjects like Metabolomics and Cancer Research, Analytical Techniques in Metabolomics, Applications of Separation Sciences in Metabolomics, Frontiers of Metabolomics Research, Systems biology and Computational Biology, Bioinformatics and Advancements, Clinical Metabolomics and Lipidomics, to mention a few. The three days event implanted a firm relation of upcoming strategies in the field of Metabolomics with the scientific community. The conceptual and applicable knowledge shared, will also foster organizational collaborations to nurture scientific accelerations.

We are thankful to all our speakers for encouraging and supporting us to conduct the conference and catapulting the same to pinnacle of success.

The Organizing Committee would like to thank the moderators Dr. Paul M. Yen, Duke-NUS Medical School, Singapore and Dr. Scott J. Tebbutt, University of British Columbia & PROOF Centre of Excellence, Canada for their contributions which resulted in smooth functioning of the conference.

A series of invited lectures by Honorable guests and members of the Keynote Forum marked the commencement of the event. Prominent scientists like Kenneth K. Wu from CMU, NHRI and NTHU, Taiwan; Walter Wahli from Nanyang Technological University, Singapore; Philipp Kaldis from National University of Singapore, Singapore; Scott J. Tebbutt from University of British Columbia & PROOF Centre of Excellence, Canada; Takeshi Kimura from Ajinomoto Co., Inc., Japan; Sean Pin Ng from Singapore Phenome Center, Singapore; Paul M. Yen from Duke-NUS Medical School, Singapore; Maximilian Zucker from numares HEALTH AG, Germany; Jaleel k Ahmed from Babylon University, Iraq; gave their fruitful contributions in the form of highly informative presentations and made the conference a top notch one.

Conference Series llc LTD is prerogative to thank the Organizing Committee Members, Keynote speakers, Chair and Co-chairs on transcribing the plenary sessions and workshops in a diversified and variegate manner to make this conference an enviable artefact.

Conference Series llc LTD offers its heartfelt appreciation to our sponsor “Bruker, Germany”. We also express our sincere thanks to all the media partners for the promotion of our event to glory.

The supporting Sponsor who continuously shows confidence in our conferences was Bruker.

The best poster presentations were awarded by Dr. Björn Riefke Bayer Pharma AG, Germany to:

Fatima AL-Khelaifi, Anti-Doping Lab, Qatar

Conference Series llc LTD, on behalf of the conference, congratulates the Best poster awardees for their outstanding performance in the field of Metabolomics and appreciates all the participants who put their efforts in poster presentations and sincerely wishes them success in future endeavors.

Conference Series llc LTD 8th International Conference and Exhibition on Metabolomics would not have reached the pinnacle if not with the support of international, multi-professional steering committee and coordination of the Journal of Metabolomics: Open Access, Journal of Computer Science and Systems Biology; hence, we express our deep sense of gratitude.

After the successful completion of six consecutive conferences we are glad to announce our next upcoming conferences which is going to be held in Japan,

 “11th International Conference and Exhibition on Metabolomics and Systems Biology” which is going to be held during May 17-19, 2018 in Tokyo, Japan.

 


Past Reports  Gallery  

Metabolomics Congress 2016

Past Reports  Gallery  

Metabolomics-2015

Past Reports  Gallery  

To Collaborate Scientific Professionals around the World

Conference Date March 28-29, 2019

Speaker Opportunity

Day 1

Supported By

Journal of Metabolomics:Open Access Journal of Computer Science & Systems Biology Journal of Proteomics & Bioinformatics Journal of Data Mining in Genomics & Proteomics

All accepted abstracts will be published in respective Conference Series LLC LTD International Journals.

Abstracts will be provided with Digital Object Identifier by


Media partners & Collaborators & Sponsors

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

mediapartner

Media Partner

Collaboration

Collaboration

What People Say....

It is an exciting and wonderful experience during the 3-days meeting, which gives us the opportunity to get to know so many friends and inspire new ideas in our research. Also, the meeting organization is perfect and considerate. We very appreciate all the works you have done for us. I also hope to meet these friends and new friends in the next meeting.

Speaker

Houkai Li, Professor, Shanghai University of Traditional Chinese Medicine, China

I enjoyed the conference very much. Cutting-edge and wide range of disciplines, but with a small enough group size to be conducive to excellent discussions and networking.

Speaker

Scott J. Tebbutt, Chief Scientific Officer, PROOF Centre of Excellence, Canada

Thank you as well, and you are welcome! It was a good experience, and I was appreciative of the opportunity to meet and talk with all the conference participants.

Speaker

Jon Rask, Research Scientist, NASA, USA

Congratulate you and your whole team on the grand success of the Conference held in Philadelphia, USA. It was well planned and organized. Since all members of the managing committee were very friendly and sincere we felt homely at all moments. Moreover, my especial thanks are due to you and your team for the kind cooperation, hospitality and management. I look forward and wish you the best for the next meeting to be held in 2016. Once again, I thank you and all the crew members associated with the 4th International Conference and Exhibition on Metabolomics & Systems Biology. With my sincere regards and best wishes, to you and your team.

Speaker

Abdelmegid I. Fahmi, Professor, Menoufia University, Egypt

I was pleased to have the opportunity to learn about the development of new techniques to study the abundance and flux of metabolites. Moreover, new platforms to analyze data were presented at the meeting, a key aspect for any research project. Additionally, the meeting provided an excellent opportunity for networking. Overall, I am grateful for my experience and the opportunity to present my project at the meeting.

Speaker

Inmaculada Martinez-Reyes, Scientific Postdoctoral Researcher, Northwestern University, USA

It was my great honor to be a Keynote Speaker and to know new colleagues working in the field of metabolomics worldwide. I found that I learned quite a lot from this conference. Thank you very much for organizing this wonderful meeting!

Speaker

Jian Z Hu, Principal investigator, Pacific Northwest National Laboratory, USA

The meeting was well organized from a practical and administrative aspect but the combination of a small meeting with few attendees and diverse aspects of metabolomics did make the conference a bit thin in returning scientific value to my investment in time and money to the meeting. My proposal would be to select fewer main topics.

Speaker

Lars Lofgren, Associate principal scientist, AstraZeneca R&D, Sweden